The company was founded in 2016 to commercialize technology from the University of Texas and is headquartered in Lafayette, Colorado. Its franchise product is designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Neuraptive is dedicated to bringing novel therapeutic technology for the acute surgical repair of injured peripheral nerves.